pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression

被引:0
作者
Min Wang
Xingjiao Lu
Xueguang Dong
Fengyun Hao
Zimin Liu
Guangzhen Ni
Dong Chen
机构
[1] People’s Hospital of Laiwu,Department of Clinical Laboratory
[2] People’s Hospital of Zhangqiu,Department of Internal Neurology
[3] The Affiliated Hospital of Qingdao University,Department of General Surgery
[4] People’s Hospital of Weifang,Department of Clinical Laboratory
来源
World Journal of Surgical Oncology | / 13卷
关键词
Pancreatic cancer; ERK1/2; Bcl-2; Bax; Gemcitabine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 110 条
  • [1] Squadroni M(2010)Chemotherapy in pancreatic adenocarcinoma Eur Rev Med Pharmacol Sci. 14 386-3894
  • [2] Fazio N(1997)Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol. 15 2403-13
  • [3] Burris HA(1996)A phase II trial of gemcitabine in patients with 5-FU-refractory pancreatic cancer Ann Oncol. 7 347-53
  • [4] Moore MJ(1999)Current chemotherapeutic possibilities in pancreaticobiliary cancer Ann Oncol. 10 S157-61
  • [5] Anderson J(1999)Experimental drugs and drug combinations in pancreatic cancer Ann Oncol. 10 S234-8
  • [6] Rothenberg ML(2003)Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death Oncogene. 22 3243-51
  • [7] Moore MJ(2006)Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma Ann Surg Oncol 13 933-9
  • [8] Cripps MC(2013)ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells J Int Med Res. 41 300-6
  • [9] van Riel JMGH(2010)The biochemistry of apoptosis Nature. 407 770-6
  • [10] van Groeningen CJ(2000)Role of the BH3 (bcl-2 homology 3) domain in the regulation of apoptosis and bcl-2-related proteins Biochem Soc Trans. 28 51-6